Workflow
可靠股份(301009) - 2024 Q1 - 季度财报(更新)
301009Coco Healthcare(301009)2024-06-03 08:42

Financial Performance - The company's revenue for Q1 2024 was ¥282,967,455.35, a decrease of 11.24% compared to ¥318,794,418.07 in the same period last year[5]. - Net profit attributable to shareholders increased by 65.19% to ¥18,331,987.65 from ¥11,097,189.92 year-on-year[5]. - Basic earnings per share rose by 65.20% to ¥0.0674, compared to ¥0.0408 in the same period last year[5]. - The company reported a significant increase in accounts receivable by 15.10%, reaching ¥222,464,562.68 compared to ¥193,282,289.99 at the end of the previous year[9]. - The company’s gross profit margin improved, contributing to a net profit increase of 62.79% to ¥18,204,327.14 from ¥11,182,851.33 year-on-year[10]. - Total operating revenue for Q1 2024 was CNY 282,967,455.35, a decrease of 11.2% compared to CNY 318,794,418.07 in Q1 2023[28]. - Net profit for Q1 2024 reached CNY 18,204,327.14, an increase of 62.8% from CNY 11,182,851.33 in Q1 2023[30]. - Operating profit for Q1 2024 was CNY 20,801,784.53, compared to CNY 12,203,824.11 in Q1 2023, marking a growth of 70.5%[29]. - Earnings per share for Q1 2024 were CNY 0.0674, up from CNY 0.0408 in Q1 2023, indicating a 65.4% increase[30]. Cash Flow and Assets - The net cash flow from operating activities decreased by 33.76% to ¥13,731,198.53, down from ¥20,728,971.51 in the previous year[11]. - The company reported a total cash balance of RMB 822,319,907.76 as of March 31, 2024, down from RMB 863,061,836.17 at the beginning of the period, representing a decrease of approximately 4.3%[25]. - Total cash inflow from operating activities was ¥323,585,694.59, while cash outflow was ¥309,854,496.06, resulting in a net cash flow of ¥13,731,198.53[33]. - The cash flow from investing activities showed a net outflow of ¥23,929,423.70, compared to a net outflow of ¥36,998,015.24 in the previous year[34]. - Cash inflow from financing activities was ¥200,000.00, while cash outflow was ¥31,357,188.47, leading to a net cash flow of -¥31,157,188.47[34]. - The total cash and cash equivalents at the end of Q1 2024 were ¥756,807,716.81, down from ¥796,442,379.58 at the beginning of the quarter[34]. - The company’s total assets at the end of Q1 2024 were ¥1,986,977,189.81, a slight decrease of 0.25% from ¥1,992,017,074.35 at the end of the previous year[5]. - The company’s non-current assets totaled RMB 795,774,435.42, an increase from RMB 787,288,364.48 at the beginning of the period[25]. - The company’s inventory stood at RMB 116,560,357.15, up from RMB 114,820,040.22, indicating a rise of approximately 1.5%[25]. - Total liabilities as of Q1 2024 amounted to CNY 549,060,556.15, slightly up from CNY 542,404,899.28 in the previous year[29]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 14.844 million[14]. - The largest shareholder, Jin Liwei, holds 59.26% of shares, totaling 161,099,964 shares[14]. - The second largest shareholder, Packwood Enterprises Limited, holds 2.76% of shares, totaling 7,500,000 shares[14]. - The company has a total of 3,879,500 shares held by Guotai Junan Securities Asset Management[14]. - The company has a total of 2,625,573 shares held by Wu Zhiwei, with 656,393 shares added during the period[17]. Corporate Governance - The company’s board of directors and supervisory board were re-elected on January 3, 2024[18]. - The company has not reported any changes in the participation of major shareholders in margin trading[15]. - The company’s actual controller underwent a change due to personal circumstances, but it is not expected to significantly impact the company's management[19]. Research and Development - The company’s research and development expenses were ¥10,215,780.02, a slight decrease of 2.07% from ¥10,431,901.05 in the previous year[10]. - The company has not disclosed any new product or technology developments in the current report[15]. - The company has not reported any market expansion or acquisition strategies in the current report[15]. - The company has not indicated any future performance guidance in the current report[15]. Share Repurchase - The company approved a share repurchase plan with a total fund of no less than RMB 30 million and no more than RMB 50 million, with a maximum repurchase price of RMB 13 per share[20]. - As of April 1, 2024, the company had repurchased a total of 3,345,500 shares, accounting for 1.23% of the total share capital, with a total transaction amount of RMB 30,096,672[21]. - The company repurchased shares, resulting in a significant change in financing cash flow, which decreased by 31,157,188.47, compared to a positive cash flow of ¥100,000.00 in the previous year[12].